Transplantation of R-GSIK scaffold with mesenchymal stem cells improves neuroinflammation in a traumatic brain injury model
Authors:
Open Access
- 27 July 2020
- journal article
- research article
- Published by Springer Nature in Cell and tissue research
- Vol. 382 (3) , 575-583
Abstract
Neural tissue engineering has been introduced as a novel therapeutic strategy for traumatic brain injury (TBI). Transplantation of mesenchymal stem cells (MSCs) has been demonstrated to improve functional outcome of brain injury, and RADA4GGSIKVAV (R-GSIK), a self-assembling nano-peptide scaffold, has been suggested to promote the behavior of stem cells. This study was designed to determine the ability of the R-GSIK scaffold in supporting the effects of MSCs on motor function activity and inflammatory responses in an experimental TBI model. A significant recovery of motor function was observed in rats that received MSCs+R-GSIK compared with the control groups. Further analysis showed a reduction in the number of reactive astrocytes and microglial cells in the MSCs and MSCs+R-GSIK groups compared with the control groups. Furthermore, western blot analysis indicated a significant reduction in pro-inflammatory cytokines, such as TLR4, TNF, and IL6, in the MSCs and MSCs+R-GSIK groups compared with the TBI, vehicle, and R-GSIK groups. Overall, this study strengthens the idea that the co-transplantation of MSCs with R-GSIK can increase functional outcomes by preparing a beneficial environment. This improvement may be explained by the immunomodulatory effects of MSCs and the self-assembling nano-scaffold peptide.Keywords
Funding Information
- National Institute for Medical Research Development
- Iran National Science Foundation (Neuroscience Chair)
- Mashhad University of Medical Sciences (Student Grant)
This publication has 45 references indexed in Scilit:
- The role of Toll-like receptor signaling pathways in cerebrovascular disorders: the impact of spreading depolarizationJournal of Neuroinflammation, 2020
- Cellular therapy for traumatic neurological injuryPediatric Research, 2017
- Use of human mesenchymal stem cell treatment to prevent anhedonia in a rat model of traumatic brain injuryRestorative Neurology and Neuroscience, 2016
- Chronic neurodegenerative consequences of traumatic brain injuryRestorative Neurology and Neuroscience, 2014
- Absence of TLR4 Reduces Neurovascular Unit and Secondary Inflammatory Process after Traumatic Brain Injury in MicePLOS ONE, 2013
- Microglial activation induced by brain trauma is suppressed by post-injury treatment with a PARP inhibitorJournal of Neuroinflammation, 2012
- Concise Review: Mesenchymal Stem Cells: Their Phenotype, Differentiation Capacity, Immunological Features, and Potential for HomingStem Cells, 2007
- Neurons Derived From Human Mesenchymal Stem Cells Show Synaptic Transmission and Can Be Induced to Produce the Neurotransmitter Substance P by Interleukin-1αStem Cells, 2005
- The neuroprotective role of inflammation in nervous system InjuriesJournal of Neurology, 2004
- Leukocyte Infiltration, Neuronal Degeneration, and Neurite Outgrowth after Ablation of Scar-Forming, Reactive Astrocytes in Adult Transgenic MiceNeuron, 1999